Complete Guide to Dupixent (Dupilumab) Pharmacokinetics
Overview
Dupixent (Dupilumab) is a mAb used in the Immunology therapeutic area. It is indicated for Atopic dermatitis. Simulate Dupixent (dupilumab) pharmacokinetics. This PK simulator models the anti-IL-4Rα monoclonal antibody that inhibits IL-4 and IL-13 signaling for atopic dermatitis.
Mechanism of Action
Dupixent (Dupilumab) exerts its pharmacological effect by targeting IL-4Rα. As a mAb, it modulates this target to achieve therapeutic efficacy in Atopic dermatitis. Understanding the target engagement is critical for interpreting the pharmacokinetic-pharmacodynamic (PK/PD) relationship and optimizing dosing regimens.
Key Pharmacokinetic Parameters
This 1-CMT PopPK model for Dupixent (Dupilumab) characterizes the time-course of drug concentrations following SC administration. Key parameters such as clearance (CL), volume of distribution (Vd), and absorption rate constant (Ka) define the drug's disposition. Use the interactive simulator below to explore these parameters in detail.
Dosing & Administration
Dupixent (Dupilumab) is administered via the SC route. Subcutaneous administration provides sustained absorption from the injection site. Bioavailability and absorption rate may vary by injection site and volume.
Dosing recommendations should always follow approved prescribing information. The interactive simulator allows you to explore different dosing scenarios and their impact on drug exposure metrics such as AUC, Cmax, and Ctrough.
Clinical Considerations
In the Immunology therapeutic area, for the treatment of Atopic dermatitis, understanding the pharmacokinetics of Dupixent (Dupilumab) is essential for dose optimization and therapeutic drug monitoring. Key clinical factors that may affect Dupixent (Dupilumab) pharmacokinetics include:
- •Body weight and body composition
- •Renal and hepatic function
- •Drug-drug interactions and concomitant medications
- •Age, sex, and genetic polymorphisms
Interactive Dupixent (Dupilumab) PK Simulator
Explore Dupixent (Dupilumab) pharmacokinetics interactively. Adjust doses, dosing intervals, and patient covariates to visualize concentration-time profiles in real time.
Frequently Asked Questions
What is the half-life of Dupixent (Dupilumab)?
The elimination half-life of Dupixent (Dupilumab) depends on patient-specific factors. Use our interactive Dupixent (Dupilumab) PK simulator to explore concentration-time profiles and estimate half-life under different dosing scenarios.
How is Dupixent (Dupilumab) administered?
Dupixent (Dupilumab) is administered via the SC route. It is indicated for Atopic dermatitis. As a mAb, dosing regimens should follow approved prescribing information and clinical guidelines.
What are the key PK parameters of Dupixent (Dupilumab)?
Key pharmacokinetic parameters for Dupixent (Dupilumab) include clearance (CL), volume of distribution (Vd), and elimination half-life. Our interactive simulator uses a 1-CMT PopPK model to characterize the pharmacokinetics of Dupixent (Dupilumab).
Can I simulate Dupixent (Dupilumab) dosing scenarios for free?
Yes! PKPDBuilder offers a completely free, interactive Dupixent (Dupilumab) PK simulator based on published pharmacometric models. No login required. Use it to explore different doses, dosing intervals, and patient covariates.
⚠️ Disclaimer
This guide is for research and educational purposes only. It is not intended for clinical decision-making or patient dosing. Parameters are derived from published literature and represent population estimates. Always consult approved prescribing information for clinical use.